A recent study found that HIV positive people may be able to achieve CD4 counts that are similar to HIV negative people if they stay on combination drug therapy for long enough and their viral loads are suppressed below 50 copies/milliliter. However, some researchers caution that this benefit may only be available to patients with ideal responses to combination therapy, a factor that could limit its relevance to patients in poorer countries.